Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
YETI Holdings
YETI
5
Teradata Corp
TDC
US OptionsDetailed Quotes
XBI250502C78000
- 5.65
- 0.000.00%
15min DelayClose May 2 16:00 ET
0.00High0.00Low
0.00Open5.65Pre Close0 Volume1.04K Open Interest78.00Strike Price0.00Turnover3418.76%IV8.14%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier-4DDays to Expiry5.65Extrinsic Value100Contract SizeAmericanOptions Type0.9499Delta0.0293Gamma13.69Leverage Ratio-313.4480Theta0.0000Rho13.00Eff Leverage0.0001Vega
SPDR S&P Biotech ETF Newsroom
Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Here Are the Major Earnings Before the Open Tomorrow
Vertex Pharma Extends Selloff as Wolfe Downgrades After Q1 Miss
S&P 500's Five Most Overbought and Oversold Stocks
SA Analyst Upgrades: TSLA, MSFT, AMD, PLTR, VRTX, ONON, CB
This House of Representative Just Bought Up To $915K In AbbVie Stock
Preview: Natera's Earnings
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Natera's Prospera Heart With DQS Cuts False Positives By Over 37%, Outperforming Dd-cfDNA Percentage Alone, AJT Publication Shows
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?
Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator
Express News | Shares of Vaccine and Gene Therapy Stocks Are Trading Lower After FDA Commissioner Marty Makary Reportedly Named Vinay Prasad as Director of the Center for Biologics and Research
Express News | 'FDA Names Vinay Prasad as New Head of Vaccines, Biologics'- Bloomberg Law
Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target
Guggenheim Maintains Buy on Neurocrine Biosciences, Raises Price Target to $165
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
This Vertex Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
Neurocrine Biosciences Analyst Ratings
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
